[REVISION HISTORY]

India pharma and MedTech self‑reliance drive

Updated 1 time since CLSTR started tracking revisions of this situation.

What changed

2026-08-06 19:23 UTC → 2026-08-06 19:24 UTC · added ~~removed~~

In late July ~~2026, India’s~~ 2026 Health Minister JP Nadda opened the LUB Pharma Conclave‑2026, ~~stressing that micro, small and medium enterprises (MSMEs) are essential~~ emphasizing MSMEs for ~~expanding domestic production of~~ affordable ~~medicines, bulk drugs, vaccines~~ medicines and ~~medical devices. He highlighted India’s contribution of about~~ noting India's 60 % share of global vaccine output and $30 billion in pharma ~~exports, urging manufacturers to prioritize quality and regulatory compliance.~~ exports. A week ~~later,~~ later the government announced the 9th India Medical Device 2026 conference, to be inaugurated by Nadda on 7‑8 August. The ~~event broadened~~ conference was held in New Delhi at Bharat Mandapam (Vigyan Bhawan) on 7‑8 August 2026, organized by the ~~self‑reliance agenda to~~ Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, in partnership with FICCI. Union Minister Jagat Prakash Nadda delivered the ~~medical‑device sector,~~ keynote, while Minister of State Anupriya Patel opened the first day. The theme “Towards Viksit Bharat: Advancing India as a Global Hub for Quality Medical Devices” underscored the self‑reliance agenda, promoting domestic manufacturing, AI‑driven digital health, and export growth. Officials reiterated ~~policies such as~~ the Production Linked Incentive ~~(PLI)~~ scheme and the 2023 National Medical Devices Policy, aiming to cut the current 70‑80 % import dependence and reach a $50 billion market by 2030, with a long‑term goal of ranking among the world’s top five medical‑device manufacturing hubs by 2047.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.